Growing evidence that cannabis could reduce reliance on prescription opiates for chronic pain

A review found that cannabis used alongside opiates produced greater pain relief allowing opiate dose reduction, prevented opiate tolerance, and could potentially reduce problematic opiate use.

Lucas, Philippe·Journal of psychoactive drugs·2012·Moderate EvidenceReview

Medical Cannabis (1546)Pain (645)Addiction (1380)Harm Reduction (776)

Quick Facts

Study Type

Review

Evidence

Moderate Evidence

Sample

Not reported

What This Study Found

This review compiled evidence from preclinical and clinical sources on using cannabis as an adjunct to or substitute for opiates in chronic pain. When used together, cannabinoids and opiates produced greater cumulative pain relief than either alone, allowing patients to use lower opiate doses and experience fewer opiate side effects.

Cannabioids could prevent the development of opiate tolerance and withdrawal, and could even restore opiate effectiveness after tolerance had developed ("rekindling" opiate analgesia). Novel research suggested cannabis might also help treat problematic substance use more broadly.

The review noted that community-based medical cannabis dispensaries had been successful at providing patients with safe cannabis access and might be reducing problematic opiate use in their communities.

Key Numbers

Cannabinoids enhanced opiate analgesia. Prevented opiate tolerance and withdrawal. Could rekindle opiate effectiveness after tolerance. Community dispensaries associated with reduced opiate use.

How They Did This

Narrative review of preclinical studies, clinical evidence, and community-level observations on cannabis-opiate interactions for chronic pain. Covered both pharmacological synergies and public health implications.

Why This Research Matters

As the opioid epidemic was emerging, this review highlighted cannabis as a potential harm-reduction strategy. If cannabis could reduce opiate doses and prevent tolerance, it might reduce the cascade from prescription opiates to dependence and overdose.

The Bigger Picture

This review was prescient. Written as the opioid crisis was building, it identified cannabis as a potential off-ramp from problematic opiate use. Subsequent population-level studies found reduced opiate prescriptions and overdose deaths in states with medical cannabis laws.

What This Study Doesn't Tell Us

Narrative review with advocacy perspective. Much evidence was preclinical. Clinical data on cannabis-opiate substitution was limited. Community dispensary observations were ecological, not controlled studies. Did not address cannabis-specific risks.

Questions This Raises

?Does medical cannabis access actually reduce opiate overdose deaths at the population level?
?What cannabis formulations work best as opiate adjuncts?
?Are there risks to dual cannabis-opiate use that offset the potential benefits?

Trust & Context

Key Stat:: Cannabis could "rekindle" opiate effectiveness after tolerance
Evidence Grade:: Narrative review drawing on mixed-quality evidence. Preclinical synergy evidence was strong; clinical and community evidence was preliminary.
Study Age:: Published in 2012. Subsequent ecological studies have found associations between medical cannabis laws and reduced opiate prescriptions and overdose deaths.
Original Title:: Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain.
Published In:: Journal of psychoactive drugs, 44(2), 125-33 (2012)
Authors:: Lucas, Philippe(11)
Database ID:: RTHC-00584

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Can cannabis help reduce the need for opiates?

This review found preclinical and some clinical evidence that cannabis enhances opiate pain relief, allowing lower opiate doses. It can also prevent tolerance and may even restore effectiveness of opiates that have stopped working. However, clinical evidence was limited at the time.

Is it safe to use cannabis and opiates together?

The review focused on potential benefits but did not fully address risks. Both substances affect breathing, consciousness, and judgment. Any combination should be discussed with a doctor and carefully monitored. The potential to reduce opiate doses is the key safety argument.

Cite This Study

RTHC-00584·https://rethinkthc.com/research/RTHC-00584

APA

Lucas, Philippe. (2012). Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain.. Journal of psychoactive drugs, 44(2), 125-33.

MLA

Lucas, Philippe. "Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain.." Journal of psychoactive drugs, 2012.

RethinkTHC

RethinkTHC Research Database. "Cannabis as an adjunct to or substitute for opiates in the t..." RTHC-00584. Retrieved from https://rethinkthc.com/research/lucas-2012-cannabis-as-an-adjunct

Access the Original Study

View on PubMed

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database